Edesa Biotech (STU:RBTQ) Total Assets : €5.96 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Edesa Biotech Total Assets?

Edesa Biotech's Total Assets for the quarter that ended in Mar. 2024 was €5.96 Mil.

During the past 12 months, Edesa Biotech's average Total Assets Growth Rate was 14.80% per year. During the past 3 years, the average Total Assets Growth Rate was -0.20% per year. During the past 5 years, the average Total Assets Growth Rate was 35.50% per year. During the past 10 years, the average Total Assets Growth Rate was 22.60% per year.

During the past 13 years, Edesa Biotech's highest 3-Year average Total Assets Growth Rate was 466.40%. The lowest was -23.50%. And the median was 32.90%.

Total Assets is connected with ROA %. Edesa Biotech's annualized ROA % for the quarter that ended in Mar. 2024 was -104.24%. Total Assets is also linked to Revenue through Asset Turnover. Edesa Biotech's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Edesa Biotech Total Assets Historical Data

The historical data trend for Edesa Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edesa Biotech Total Assets Chart

Edesa Biotech Annual Data

Trend

Aug14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Assets

Get a 7-Day Free Trial

5.19

9.14

12.40

11.69

8.33

Edesa Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															9.97	8.70	8.33	7.18	5.96

Edesa Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Edesa Biotech's Total Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (A: Sep. 2023 )	+	Total Liabilities (A: Sep. 2023 )
	=	6.605	+	1.726
	=	8.33

Edesa Biotech's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	3.978	+	1.979
	=	5.96

Edesa Biotech (STU:RBTQ) Total Assets Explanation

Total Assets is connected with ROA %.

Edesa Biotech's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-6.848	/	( (7.182	+	5.957)	/ 2 )
	=	-6.848	/	6.5695
	=	-104.24 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Edesa Biotech's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (7.182	+	5.957)	/ 2 )
=	0	/	6.5695
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Edesa Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Edesa Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Edesa Biotech (STU:RBTQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Edesa Biotech Inc (STU:RBTQ) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

EDSA:USA

Address

100 Spy Court, Markham, ON, CAN, L3R 5H6

Website

https://www.edesabiotech.com

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Edesa Biotech (STU:RBTQ) Headlines

No Headlines